shared a link post in group #Biohackers Connect
The science is intriguing but incomplete. Animal data is promising. Human data is minimal.
Regulation is weak.The market is messy. Until proper clinical trials are conducted:
Caveat emptor — buyer beware.
The “Wolverine stack” peptides BPC-157 and TB-500 show promising healing effects in animals but lack solid human evidence, exist in a regulatory grey zone, and are currently sold in an unregulated market where safety, purity and efficacy remain uncertain.
economist.com/science-and..
